Jichlinski Patrice
Department of Urology, CHUV-University Hospital, 1011 Lausanne, Switzerland.
J Environ Pathol Toxicol Oncol. 2006;25(1-2):441-51. doi: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.280.
As a disease characterized by a polymorphic and fluctuant nature in its evolution, superficial transitional cell carcinoma of the bladder remains a perpetual therapeutic challenge. This raises a great interest in the development of new diagnostic and therapeutic photodynamic applications. This article describes recent facts in the field of bladder cancer photodiagnosis and gives a survey on ongoing research in photodynamic therapy. Fluorescence cystoscopy induced by different aminolevulinic acid compounds (e.g., ALA-HAL) is well accepted in the urological community as a user-friendly new diagnostic tool in the endoscopic management of bladder tumors and CIS. Photodynamic therapy based on the same photosensitizing agents remains experimental, but recent results raise hopes of new therapeutic directions.
作为一种在发展过程中具有多态性和波动性的疾病,膀胱浅表性移行细胞癌仍然是一个长期的治疗挑战。这引发了人们对开发新的诊断和治疗性光动力应用的极大兴趣。本文介绍了膀胱癌光诊断领域的最新情况,并对光动力治疗的正在进行的研究进行了综述。由不同的氨基乙酰丙酸化合物(如ALA-HAL)诱导的荧光膀胱镜检查作为膀胱肿瘤和原位癌内镜管理中一种用户友好的新诊断工具,在泌尿外科界已被广泛接受。基于相同光敏剂的光动力治疗仍处于实验阶段,但最近的结果为新的治疗方向带来了希望。